The Modern Treatment of Rheumatoid Arthritis

REFERENCES

• Hench, P. S.: The potential reversibility of rheumatoid arthritis. Am. Rheumat. Dis. 8: 90 (June) 1949.
   PubMed Web of Science ®Google Scholar
• Hench, P. S., Kendall, E. C., Slocumb, C. H., and Polley, H. F.: The effect of a hormone of the adrenal cortex (17 hydroxyll dehydrocorticosterone; compound E) and of the pituitary adrenocorticotropic hormone on rheumatoid arthritis; preliminary report. Proc. Staff Meet., Mayo Clin. 24: 181 (April 13) 1949.
   PubMed Web of Science ®Google Scholar
• Hench, P. S., Kendall, E. C., Slocumb, C. H., and Polley, H. F.: Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch. Int. Med. 85: 545 (April) 1950.
   Web of Science ®Google Scholar
• Bauer, W., Boland, E. W., Freyberg, R. H., Holbrook, W. P., and Rosenberg, E. F.: Proceedings Seventh International Congress on Rheumatic Diseases, May 31, 1949 (to be published).
   Google Scholar
• Boland, E. W., and Headley, N. E.: Effects of cortisone acetate on rheumatoid arthritis. J.A.M.A. 141: 301 (October 1) 1949.
   PubMed Web of Science ®Google Scholar
• Spies, T. D., and Stone, R. E.: Relief of the symptoms of acute gout and rheumatoid arthritis by means of pituitary adrenocorticotropic hormone (ACTH). South. M. J. 42: 720 (August) 1949.
   PubMedGoogle Scholar
• Markson, D. E.: Prolonged treatment of rheumatoid arthritis with pituitary adrenocorticotropic hormone (ACTH). J.A.M.A. 141: 458 (October 15) 1949.
   PubMed Web of Science ®Google Scholar
• Davison, R., Koets, P., Snow, W. G., and Gabrielson, L. G.: Effects of delta -5 pregnenolone in rheumatoid arthritis. Arch. Int. Med. 85: 365 (March) 1950.
   Google Scholar
• Freeman, H., Pincus, G., Johnson, C. W., Bachrach, S., McCabe, G. E., and MacGilpin, H.: Therapeutic effectiveness of delta -5 pregnenolone in rheumatoid arthritis. J.A.M.A. 142: 1124 (April 15) 1950.
   Web of Science ®Google Scholar
• Ishmael, W. K., Hellbaum, A., Kuhn, J. F., and Duffy, M.: The effects of certain steroid compounds on various manifestations of rheumatoid arthritis. J. Oklahoma State M. A. 42: 434, 1949.
   PubMedGoogle Scholar
• Ishmael, W. K., Hellbaum, A., Kuhn, J. F., Owens, J. N., and Duffy, M.: Further observations on the use of large doses of testosterone and pregnenolone in rheumatoid arthritis and allied disorders. Proceedings, Annual meeting of the American Rheumatism Association, June 24, 1950 (to be published).
   Google Scholar
• Look Magazine: June 20, 1950, page 60.
   Google Scholar
• Henderson, E., Weinberg, M., and Wright, W. A.: Endocrine review; pregnenolone. J. Clin. Endocrinol. 10: 455 (June) 1950.
   Google Scholar
• Guest, C. M., Kammerer, W. H., Cecil, R. L., and Berson, S. A.: Epinephrine, pregnenolone, and testosterone in the treatment of rheumatoid arthritis. J.A.M.A. 143: 338 (May 27) 1950.
   PubMed Web of Science ®Google Scholar
• Editorial: Deoxycortone and pregnenolone in rheumatism. Lancet 1: 1003 (May 27) 1950.
   Google Scholar
• Lewin, E., and Wassin, E.: Effect of combined injections of deoxycortone acetate and ascorbic acid on rheumatoid arthritis. Lancet 2: 993 (November 26) 1949.
   PubMedGoogle Scholar
• LeVay, D., and Laxton, G. E.: Deoxycortone acetate and ascorbic acid in the treatment of rheumatoid arthritis. Lancet 2: 1134 (December 17) 1949.
   PubMedGoogle Scholar
• Douthwaite, A. J.: Deoxycortone acetate and ascorbic acid in the treatment of rheumatoid arthritis. Lancet 2: 1244 (December 31) 1949.
   Google Scholar
• Newman, M. K.: Desoxycorticosterone acetate and ascorbic acid in the management of rheumatoid arthritis. Proceedings, Annual meeting of the American Rheumatism Association, June 24, 1950 (to be published).
   Google Scholar
• Spies, T. D., Stone, R. E., DeMaeyer, E., and Niedermeier, W.: Deoxycortone acetate and ascorbic acid versus ACTH in rheumatoid arthritis. Lancet 2: 993 (November 26) 1949.
   PubMedGoogle Scholar
• Fletcher, E., Lush, B., Buchan, G. F., and Wolff, S.: Deoxycortone acetate and ascorbic acid in rheumatoid arthritis. Lancet 1: 94 (January 14) 1950.
   Google Scholar
• Kellgren, J. N.: Deoxycortone acetate and ascorbic acid in rheumatoid arthritis. Lancet 2: 108 (December 10) 1949.
   Google Scholar
• Hartfall, S. J., and Harris, R.: Deoxycortone acetate and ascorbic acid in rheumatoid arthritis. Lancet 2: 1202 (December 24) 1949.
   Google Scholar
• Copeman, W. S. C., Duthie, J. J. R., and others: Deoxycortone acetate and ascorbic acid in rheumatoid arthritis. Lancet 1: 830 (April 29) 1950.
   PubMedGoogle Scholar
• Currie, J. D., and Will, G.: Treatment of rheumatoid arthritis with deoxycortone acetate and vitamin C. Lancet 1: 708 (April 15) 1950.
   PubMedGoogle Scholar
• Kling, D. H.: Desoxycorticosterone acetate and ascorbic acid injections in rheumatoid arthritis. J.A.M.A. 143: 791 (July 1) 1950.
   PubMed Web of Science ®Google Scholar
• Kersley, G. D., Mandel, L., and Jeffrey, M. R.: Steroid therapy in rheumatoid arthritis. Lancet 1: 703 (April 15) 1950.
   PubMedGoogle Scholar
• Kyle, L. H., and Crain, D. C.: The clinical and metabolic effects of progesterone and anhydrohydroxyprogesterone in rheumatoid arthritis. Ann. Int. Med. 32: 878 (May) 1950.
   PubMed Web of Science ®Google Scholar
• Alexander, W. R. M., and Duthie, J. J. R.: Progesterone in the treatment of rheumatoid arthritis. Lancet 1: 297 (February 18) 1950.
   PubMedGoogle Scholar
• Reich, N. E.: The use of large doses of progesterone in rheumatoid arthritis. Am. Practitioner 4: 1, 1949.
   Google Scholar
• Crain, D. C.: Dole in as an antirheumatic (to be published).
   Google Scholar
• Tillis, H. H.: A clinical evaluation of Dolcia (to be published).
   Google Scholar
• Primer on the Rheumatic Diseases. American Medical Association, 1949.
   Google Scholar
• Forestier, J.: Proceedings Seventh International Congress on Rheumatic Diseases, June 1, 1949 (to be published).
   Google Scholar